$9.78−0.16 (−1.61%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD
Climb Bio (CLYM) Income Statement
Is this a real, growing, cash-generative business, or a story propped up by accounting?
Sources Company filings FilingsHow we compute thisNot investment advice
Business enginePre-revenue: no positive revenue in any year through FY25, so the growth and margin read is withheld. Worth your attention in FY25: Share count (+453.1%) and Returns vs FCF (n/m). Both visible in the receipts below.
The four lines that matter · FY21–FY25
Revenue ($M)—
0.0
FY21→FY25CAGR —
Net income ($M)▲19.0%
−59.9
FY21→FY25CAGR —
Free cash flow ($M)▼250.5%
−54.5
no value for 2 of 5 yearsCAGR —
Diluted EPS▲42.5%
−0.88
FY21→FY25CAGR —
What the receipts whisper · what a headline number hides
Share count
+453.1%
12.3mn → 67.8mn diluted shares since FY21. Rising share count dilutes EPS. Growth must outrun it.
Returns vs FCF
n/m
$0.1M returned vs $−54.5M of FCF in FY25. Free cash flow was negative, so returns were funded from the balance sheet rather than from cash generation.
What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($M)
Margin trend · direction beats level
This filer reports no gross profit or operating income line, so those margins are not drawn.
The receipt · income statement · FY21–FY25 USD thousands except per-share & ratios · hover a line for its definition
USD thousands except per-share & ratios
| Line item | TTM † | FY25 | FY24 | FY23 | FY22 | FY21 | YoY | CAGR 21→25 |
|---|---|---|---|---|---|---|---|---|
| Revenue & profitability | ||||||||
Revenue | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — |
Cost of revenue | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — |
Gross profit | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — |
Research & development | 43,869.0 | 46,713.0 | 65,995.0 | 15,411.0 | 26,214.0 | 23,322.0 | ▼29.2% | +19.0% |
Selling, general & admin | 22,890.0 | 21,170.0 | 16,025.0 | 24,864.0 | 18,921.0 | 12,350.0 | ▲32.1% | +14.4% |
Total operating expenses | 66,759.0 | 67,883.0 | 82,020.0 | 40,275.0 | 45,135.0 | 35,672.0 | ▼17.2% | +17.5% |
Operating incomefeeds ROC rank | −66,759.0 | −67,883.0 | −82,020.0 | −40,275.0 | −45,135.0 | −35,672.0 | ▲17.2% | — |
Other income, net | 7,450.0 | 8,032.0 | 8,123.0 | 5,156.0 | −109.0 | −11,808.0 | — | — |
Pretax income | −59,309.0 | −59,851.0 | −73,897.0 | −35,119.0 | −45,244.0 | −47,480.0 | ▲19.0% | — |
Net incomePiotroski ROA ✕feeds Buffett Quality owner earnings | −59,309.0 | −59,851.0 | −73,897.0 | −35,119.0 | −45,244.0 | −47,480.0 | ▲19.0% | — |
| Per share | ||||||||
Diluted EPSbuyback-sensitive | −0.81 | −0.88 | −1.53 | −1.30 | −1.72 | −4.24 | ▲42.5% | — |
Diluted shares (mn) | 80.03 | 67.81 | 48.16 | 26.99 | 26.31 | 12.26 | ▲40.8% | +53.4% |
| Margins | ||||||||
† TTM = trailing four quarters through 2026-09-30.
1 more year of statements and CSV export are on Premium.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
These lines feed the tenet checklists: see which gates passTenets →Margins & returns continue as sector-ranked ratiosStatistics →
Annual report filed 2026-03-05 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.
Statements normalized in our fundamentals DB · Not investment advice.
Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

